Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages

Wenqi Yu,Chuan Hu,Huile Gao
DOI: https://doi.org/10.1016/j.addr.2021.113909
IF: 16.1
2021-01-01
Advanced Drug Delivery Reviews
Abstract:Breast cancer is the most common tumor in women, and the metastasis further increases the malignancy with extremely high mortality. However, there is almost no effective method in the clinic to completely inhibit breast cancer metastasis due to the dynamic multistep process with complex pathways and scattered occurring site. Nowadays, nanomedicines have been evidenced with great potential in treating cancer metastasis. In this review, we summarize the latest research advances of nanomedicines in anti-metastasis treatment. Strategies are categorized according to the metastasis dynamics, including primary tumor, circulating tumor cells, pre-metastatic niches and secondary tumor. In each different stage of metastasis process, nanomedicines are designed specifically with different functions. At the end of the review, we give our perspectives on current limitations and future directions in anti-metastasis therapy. We expect the review provides comprehensive understandings of anti-metastasis therapy for breast can-cer, and boosts the clinical translation in the future to improve women's health. (c) 2021 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?